{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:37:55Z","timestamp":1778891875485,"version":"3.51.4"},"reference-count":53,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2018,1,28]],"date-time":"2018-01-28T00:00:00Z","timestamp":1517097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Benzoyltryptamine analogues act as neuroprotective and spasmolytic agents on smooth muscles. In this study, we investigated the ability of N-salicyloyltryptamine (STP) to produce vasorelaxation and determined its underlying mechanisms of action. Isolated rat mesenteric arteries with and without functional endothelium were studied in an isometric contraction system in the presence or absence of pharmacological inhibitors. Amperometric experiments were used to measure the nitric oxide (NO) levels in CD31+ cells using flow cytometry. GH3 cells were used to measure Ca2+ currents using the whole cell patch clamp technique. STP caused endothelium-dependent and -independent relaxation in mesenteric rings. The endothelial-dependent relaxations in response to STP were markedly reduced by L-NAME (endothelial NO synthase\u2014eNOS\u2014inhibitor), jHydroxocobalamin (NO scavenger, 30 \u00b5M) and ODQ (soluble Guanylyl Cyclase\u2014sGC\u2014inhibitor, 10 \u00b5M), but were not affected by the inhibition of the formation of vasoactive prostanoids. These results were reinforced by the increased NO levels observed in the amperometric experiments with freshly dispersed CD31+ cells. The endothelium-independent effect appeared to involve the inhibition of voltage-gated Ca2+ channels, due to the inhibition of the concentration-response Ca2+ curves in depolarizing solution, the increased relaxation in rings that were pre-incubated with high extracellular KCl (80 mM), and the inhibition of macroscopic Ca2+ currents. The present findings show that the activation of the NO\/sGC\/cGMP pathway and the inhibition of gated-voltage Ca2+ channels are the mechanisms underlying the effect of STP on mesenteric arteries.<\/jats:p>","DOI":"10.3390\/molecules23020253","type":"journal-article","created":{"date-parts":[[2018,1,29]],"date-time":"2018-01-29T07:46:20Z","timestamp":1517211980000},"page":"253","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["N-Salicyloyltryptamine, an N-Benzoyltryptamine Analogue, Induces Vasorelaxation through Activation of the NO\/sGC Pathway and Reduction of Calcium Influx"],"prefix":"10.3390","volume":"23","author":[{"given":"Robson","family":"Veras","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences, Federal University of Para\u00edba (UFPB), Jo\u00e3o Pessoa 58059-900, Brazil"},{"name":"Postgraduate Program of Nutrition Science\/CCS\/Federal University of Para\u00edba (UFPB)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darizy","family":"Silva","sequence":"additional","affiliation":[{"name":"Department of Biorregulation, Federal University of Bahia (UFBA), Av. Reitor Miguel Calmon, S\/N, Vale do Canela, Salvador 40110-902, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorena","family":"Bezerra","sequence":"additional","affiliation":[{"name":"Postgraduate Program of Nutrition Science\/CCS\/Federal University of Para\u00edba (UFPB)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9ria","family":"Assis","sequence":"additional","affiliation":[{"name":"Postgraduate Program of Natural Products and Bioactive Synthetics\/CCS\/Universidade Federal da Para\u00edba (UFPB), Jo\u00e3o Pessoa 58059-900, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walma","family":"Vasconcelos","sequence":"additional","affiliation":[{"name":"Postgraduate Program of Natural Products and Bioactive Synthetics\/CCS\/Universidade Federal da Para\u00edba (UFPB), Jo\u00e3o Pessoa 58059-900, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Alustau","sequence":"additional","affiliation":[{"name":"Postgraduate Program of Natural Products and Bioactive Synthetics\/CCS\/Universidade Federal da Para\u00edba (UFPB), Jo\u00e3o Pessoa 58059-900, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Albuquerque","sequence":"additional","affiliation":[{"name":"Postgraduate Program of Natural Products and Bioactive Synthetics\/CCS\/Universidade Federal da Para\u00edba (UFPB), Jo\u00e3o Pessoa 58059-900, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fab\u00edola","family":"Furtado","sequence":"additional","affiliation":[{"name":"Postgraduate Program of Natural Products and Bioactive Synthetics\/CCS\/Universidade Federal da Para\u00edba (UFPB), Jo\u00e3o Pessoa 58059-900, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Islania","family":"Ara\u00fajo","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Federal University of Para\u00edba (UFPB), Jo\u00e3o Pessoa 58059-900, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F\u00e1tima","family":"Azevedo","sequence":"additional","affiliation":[{"name":"Postgraduate Program of Natural Products and Bioactive Synthetics\/CCS\/Universidade Federal da Para\u00edba (UFPB), Jo\u00e3o Pessoa 58059-900, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thais","family":"Ribeiro","sequence":"additional","affiliation":[{"name":"Postgraduate Program of Natural Products and Bioactive Synthetics\/CCS\/Universidade Federal da Para\u00edba (UFPB), Jo\u00e3o Pessoa 58059-900, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Barbosa-Filho","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Federal University of Para\u00edba (UFPB), Jo\u00e3o Pessoa 58059-900, Brazil"},{"name":"Postgraduate Program of Natural Products and Bioactive Synthetics\/CCS\/Universidade Federal da Para\u00edba (UFPB), Jo\u00e3o Pessoa 58059-900, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanley","family":"Gutierrez","sequence":"additional","affiliation":[{"name":"Postgraduate Program of Natural Products and Bioactive Synthetics\/CCS\/Universidade Federal da Para\u00edba (UFPB), Jo\u00e3o Pessoa 58059-900, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isac","family":"Medeiros","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Federal University of Para\u00edba (UFPB), Jo\u00e3o Pessoa 58059-900, Brazil"},{"name":"Postgraduate Program of Natural Products and Bioactive Synthetics\/CCS\/Universidade Federal da Para\u00edba (UFPB), Jo\u00e3o Pessoa 58059-900, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2018,1,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","article-title":"2013 esh\/esc guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the european society of hypertension (esh) and of the european society of cardiology (esc)","volume":"34","author":"Mancia","year":"2013","journal-title":"Eur. Heart J."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Kaye, A.D., Kaye, A.M., and Urman, R.D. (2015). Peripheral vasodilators. Essentials of Pharmacology for Anesthesia, Pain Medicine, and Critical Care, Springer.","DOI":"10.1007\/978-1-4614-8948-1"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1161\/CIRCULATIONAHA.110.971580","article-title":"Device-based antihypertensive therapy: Therapeutic modulation of the autonomic nervous system","volume":"123","author":"Krum","year":"2011","journal-title":"Circulation"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1517\/13543784.2012.681046","article-title":"Angiotensin ii type 2 receptor agonists\u2014Where should they be applied?","volume":"21","author":"Steckelings","year":"2012","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0031-6997(25)06663-3","article-title":"Nitric oxide: Physiology, pathophysiology and pharmacology","volume":"43","author":"Moncada","year":"1991","journal-title":"Pharmacol. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1056\/NEJM199312303292706","article-title":"The l-arginine-nitric oxide pathway","volume":"329","author":"Moncada","year":"1993","journal-title":"NEJM"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.1038\/sj.bjp.0706458","article-title":"The discovery of nitric oxide and its role in vascular biology","volume":"147","author":"Moncada","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/bph.12217","article-title":"Biological nitric oxide signalling: Chemistry and terminology","volume":"169","author":"Heinrich","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1056\/NEJM199911043411907","article-title":"Calcium-antagonist drugs","volume":"341","author":"Abernethy","year":"1999","journal-title":"NEJM"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"247S","DOI":"10.1111\/j.1365-2125.1985.tb02810.x","article-title":"Calcium channel antagonists: Pharmacological considerations","volume":"20","author":"Rampe","year":"1985","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1146\/annurev.pharmtox.37.1.361","article-title":"Molecular determinants of drug binding and action on L-type calcium channels","volume":"37","author":"Hockerman","year":"1997","journal-title":"Ann. Rev. Pharm. Toxicol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ejphar.2012.09.047","article-title":"Tonic arterial contraction mediated by L-type Ca2+ channels requires sustained Ca2+ influx, g protein-associated Ca2+ release, and rhoa\/rock activation","volume":"697","author":"Castellano","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0031-6997(25)06783-3","article-title":"International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin)","volume":"46","author":"Hoyer","year":"1994","journal-title":"Pharmacol. Rev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1055\/s-2006-931576","article-title":"Aeruginascin, a trimethylammonium analogue of psilocybin from the hallucinogenic mushroom inocybe aeruginascens","volume":"72","author":"Jensen","year":"2006","journal-title":"Planta Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0091-3057(00)00484-6","article-title":"Anticonvulsant properties of n-salicyloyltryptamine in mice","volume":"68","author":"Oliveira","year":"2001","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/sj.bjp.0705471","article-title":"N-salicyloyltryptamine, a new anticonvulsant drug, acts on voltage-dependent Na+, Ca2+ and K+ ion channels","volume":"140","author":"Mafra","year":"2003","journal-title":"Br. J. Pharm."},{"key":"ref_17","first-page":"230745","article-title":"Bioassay-guided evaluation of antinociceptive effect of n-salicyloyltryptamine: A behavioral and electrophysiological approach","volume":"2010","author":"Quintans","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.farmac.2005.04.001","article-title":"Nb-benzoyltryptamine derivatives with relaxant activity in guinea-pig ileum","volume":"60","author":"Gutierrez","year":"2005","journal-title":"Farmaco"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s10565-013-9245-2","article-title":"Effect of N-salicyloyltryptamine (stp), a novel tryptamine analogue, on parameters of cell viability, oxidative stress, and immunomodulation in raw 264.7 macrophages","volume":"29","author":"Gasparotto","year":"2013","journal-title":"Cell Biol. Toxicol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/cvr\/cvs182","article-title":"Arterial endothelial cells: Still the craftsmen of regenerated endothelium","volume":"95","author":"Hagensen","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3109\/07853890.2011.585658","article-title":"Nitric oxide: Orchestrator of endothelium-dependent responses","volume":"44","author":"Feletou","year":"2012","journal-title":"Ann. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0026-895X(25)09113-8","article-title":"Characterization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase","volume":"50","author":"Schrammel","year":"1996","journal-title":"Mol. Pharmacol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1042\/CS20090096","article-title":"Edhf: An update","volume":"117","author":"Feletou","year":"2009","journal-title":"Clin. Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1111\/j.1476-5381.2011.01276.x","article-title":"Endothelium-mediated control of vascular tone: Cox-1 and cox-2 products","volume":"164","author":"Feletou","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1042\/bj3570593","article-title":"Nitric oxide synthases: Structure, function and inhibition","volume":"357","author":"Alderton","year":"2001","journal-title":"Biochem. J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jinorgbio.2004.10.016","article-title":"Structure-function studies on nitric oxide synthases","volume":"99","author":"Li","year":"2005","journal-title":"J. Inorg. Biochem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0014-2999(93)90210-9","article-title":"Differential effects of hydroxocobalamin on relaxations induced by nitrosothiols in rat aorta and anoccygeus muscle","volume":"241","author":"Li","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0022-3565(24)37434-8","article-title":"Spectroscopic studies of nitric oxide (no) interactions with cobalamins: Reaction of no with superoxocobalamin(iii) likely accounts for cobalamin reversal of the biological effects of no","volume":"285","author":"Kruszyna","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.2174\/138945012802002348","article-title":"Cardiovascular therapeutics targets on the no-sgc-cgmp signaling pathway: A critical overview","volume":"13","author":"Evora","year":"2012","journal-title":"Curr. Drug Targets"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1146\/annurev-biochem-050410-100030","article-title":"Structure and regulation of soluble guanylate cyclase","volume":"81","author":"Derbyshire","year":"2012","journal-title":"Annu. Rev. Biochem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2174\/187152508785909555","article-title":"Cardiovascular effects of modulators of soluble guanylyl cyclase activity","volume":"6","author":"Hoenicka","year":"2008","journal-title":"Cardiovasc. Hematol. Agents Med. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BFb0032675","article-title":"Physiological role of cgmp and cgmp-dependent protein kinase in the cardiovascular system","volume":"113","author":"Walter","year":"1989","journal-title":"Rev. Physiol. Biochem. Pharmacol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/0016-5085(84)90096-9","article-title":"Calcium channels in smoth muscle","volume":"87","author":"Karaki","year":"1984","journal-title":"Gastroenterology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0031-6997(24)01321-8","article-title":"Calcium movements, distribution, and functions in smooth muscle","volume":"49","author":"Karaki","year":"1997","journal-title":"Pharmacol. Rev."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"17786","DOI":"10.1016\/S0021-9258(18)38232-2","article-title":"Cdna cloning of a dihydropyridine-sensitive calcium channel from rat aorta. Evidence for the existence of alternatively spliced forms","volume":"265","author":"Koch","year":"1990","journal-title":"J. Biol. Chem."},{"key":"ref_36","first-page":"C411","article-title":"Calcium channels in excitable cells: Divergent genotypic and phenotypic expression of \u03b11-subunits","volume":"36","author":"Boldem","year":"1994","journal-title":"Am. J. Physiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1085\/jgp.104.6.1019","article-title":"Longterm regulation of calcium channels in clonal pituitary cells by epidermal growth factor, insulin, and glucocorticoids","volume":"104","author":"Meza","year":"1994","journal-title":"J. Gen. Physiol."},{"key":"ref_38","unstructured":"Almeida, R., Barbosa Filho, J.M., Souza, M.F.V., Gutierrez, J.C., Silva, D.A., and Quintans, L.J. (2005). Novo Derivado Benzoiltriptam\u00ednico e Processo Para Sua Obten\u00e7\u00e3o. (Patent PI 0304393-2 A2)."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1440-1681.2010.05383.x","article-title":"Unravelling the cardiovascular effects induced by alpha-terpineol: A role for the nitric oxide-cgmp pathway","volume":"37","author":"Ribeiro","year":"2010","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1476-5381.1990.tb14717.x","article-title":"l-ng-nitro arginine (l-arginine reversible inhibitor of endothelium-dependent vasodilatation in vitro)","volume":"99","author":"Moore","year":"1990","journal-title":"Br. J. Pharmacol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1161\/01.RES.0000082524.34487.31","article-title":"Regulation of nitric oxide-sensitive guanylyl cyclase","volume":"93","author":"Friebe","year":"2003","journal-title":"Circ. Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0026-895X(25)10233-2","article-title":"Potent and selective-inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-1,2,4 oxadiazolo 4,3-a quinoxalin-1-one","volume":"48","author":"Garthwaite","year":"1995","journal-title":"Mol. Pharm."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/FJC.0b013e31829013ff","article-title":"Participation of nitric oxide pathway in the relaxation response induced by e-cinnamaldehyde oxime in superior mesenteric artery isolated from rats","volume":"62","author":"Veras","year":"2013","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_44","first-page":"H300","article-title":"Mechanism of Ca2+ release and entry during contraction elicited by norepinephrine in rat resistance arteries","volume":"276","author":"Lagaud","year":"1999","journal-title":"Am. J. Physiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/nprot.2008.71","article-title":"Isolation of endothelial cells from fresh tissues","volume":"3","author":"Rousch","year":"2008","journal-title":"Nat. Protoc."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.vph.2011.11.006","article-title":"Ethanol induces vascular relaxation via redox-sensitive and nitric oxide-dependent pathways","volume":"56","author":"Rocha","year":"2012","journal-title":"Vasc. Pharmacol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nprot.2007.54","article-title":"A protocol for isolation and culture of human umbilical vein endothelial cells","volume":"2","author":"Baudin","year":"2007","journal-title":"Nat. Protoc."},{"key":"ref_48","first-page":"451","article-title":"Immunomagnetic purification of human microvessel endothelial cells using dynabeads coated with monoclonal antibodies to pecam-1","volume":"62","author":"Hewett","year":"1993","journal-title":"Eur. J. Cell Biol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/ajh.20904","article-title":"Flow cytometric evaluation of circulating endothelial cells: A new protocol for identifying endothelial cells at several stages of differentiation","volume":"82","author":"Ozdogu","year":"2007","journal-title":"Am. J. Hematol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0008-6363(98)00051-0","article-title":"Effects of vasodilators and perfusion pressure on coronary flow and simultaneous release of nitric oxide from guinea pig isolated hearts","volume":"38","author":"Fujita","year":"1998","journal-title":"Cardiovasc. Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/(SICI)1521-4109(20000401)12:6<425::AID-ELAN425>3.0.CO;2-6","article-title":"Novel calibration method for nitric oxide microsensors by stoichiometrical generation of nitric oxide from snap","volume":"12","author":"Zhang","year":"2000","journal-title":"Electroanalysis"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Serpe, M., and Zhang, X. (2007). The principles, development and application of microelectrodes for the in vivo determination of nitric oxide. Electrochemical Methods for Neuroscience, CRC Press\/Taylor & Francis.","DOI":"10.1201\/9781420005868.ch21"},{"key":"ref_53","unstructured":"Schmidt, K., and Mayer, B. (1998). Determination of NO with a clark-type electrode. Methods in Molecular Biology, Humana Press."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/23\/2\/253\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T14:52:49Z","timestamp":1760194369000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/23\/2\/253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,28]]},"references-count":53,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,2]]}},"alternative-id":["molecules23020253"],"URL":"https:\/\/doi.org\/10.3390\/molecules23020253","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,28]]}}}